anaphylaxis
Conditions
Interventions
Observation group:None
Sponsors
Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Patients who visited any participating center between 2022 and 2024, with a diagnosis meeting the 2020 WAO severe allergic reaction guidelines and clinically diagnosed as 'anaphylactic shock'; 2. Type of visit is not limited (emergency, outpatient, inpatient, etc. are all acceptable); 3. Complete medical records, meeting the basic data collection requirements for the study.
Exclusion criteria
Exclusion criteria: 1.Those whose shock symptoms are confirmed to be caused by non-allergic factors through differential diagnosis; 2.Those whose initial diagnosis or core diagnostic process occurred outside the research period from 2022 to 2024; 3.Cases where the crucial diagnostic information is severely lacking and cannot be traced;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Proportion of triggers;Treatment (use of key drugs such as adrenaline, respiratory support [intubation], cardiopulmonary resuscitation, and other interventions);Prognostic outcome (improved/hospital treatment/death/unknown); | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient characteristics; | — |
Countries
China
Contacts
Public ContactZhu Rongfei
Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology
Outcome results
None listed